Bonesupport Holding AB (publ) (LON:0RQO)

Market Cap	1.57B +50.2%
Revenue (ttm)	105.72M +25.2%
Net Income	20.51M +78.9%
EPS	0.31 +79.0%
Shares Out	n/a
PE Ratio	77.18
Forward PE	44.67
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,215
Open	317.20
Previous Close	322.60
Day's Range	312.40 - 321.40
52-Week Range	167.55 - 339.40
Beta	0.29
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 22, 2026

About Bonesupport Holding AB

Bonesupport Holding AB (publ), an orthobiologics company, develops and commercializes injectable bio-ceramic bone graft substitutes in the United States, Europe, and internationally. The company offers CERAMENT Bone Void Filler, an injectable ceramic bone graft substitute that remodels to host bone; CERAMENT G, an injectable ceramic bone graft substitute that remodels to host bone and elutes Gentamicin during the critical first 30 days of bone healing, as well as treats and prevents bone infection; and CERAMENT V, an injectable ceramic bone gra...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1999
• Employees: 174
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RQO

Financial Performance

In 2025, Bonesupport Holding AB's revenue was 1.17 billion, an increase of 30.70% compared to the previous year's 898.73 million. Earnings were 142.15 million, an increase of 6.28%.

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Nov 10, 2026

Data Sources Report a data error